Surgepays is trading 25.99% down at $0.18 after its quarterly report warned of substantial doubt about the company’s ability to continue as a going concern.
- First-half net loss reached $10.76 million, with significant cash consumption and limited liquidity.
- The filing delay and additional financial-disclosure concerns may have intensified selling.
- The report also cited second-quarter revenue growth and profitability.